SKYSTAR BIO-PHARMACEUTICAL CO (SKBI) [Rocket]

In millions, except per share items	Dec-31-13	Dec-31-12	Dec-31-11	Dec-31-10	Dec-31-09	Dec-31-08	Dec-31-07	Dec-31-06
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Total interest expense			0.4
Net interest income			0.2	-0.1
Gain on sale of investments, net	-0.1	0.0	1.4	-0.6
Total non-interest income	-0.1	0.0	1.4	-0.6
Pre-tax income	12.9	8.4	16.5	17.4	10.9	7.1	-0.9	1.7
Income taxes	2.4	2.2	2.9	3.3	2.0	1.5	1.0	0.5
Tax rate	18.6%	25.9%	17.4%	19.0%	18.7%	21.5%		29.6%
Net income	10.5	6.2	13.7	14.1	8.9	5.6	-2.0	1.2
Net margin	24.8%	18.5%	25.1%	30.1%	26.2%	21.9%	-13.0%	12.0%

Basic EPS	$1.38	$0.83	$1.90	$1.98	$1.65	$1.53	($0.15)	$0.11
Diluted EPS	$1.38	$0.83	$1.90	$1.97	$1.62	$1.53	($0.15)	$0.09

Shares outstanding (basic)	7.7	7.5	7.2	7.1	5.4	3.6	13.5	11.1
Shares outstanding (diluted)	7.7	7.5	7.2	7.1	5.5	3.6	13.5	12.5

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.